Drug profile · INN
nalbuphine hydrochloride
NALBUPHINE HYDROCHLORIDE
nalbuphine hydrochloride (NALBUPHINE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta agonist. Route of administration: intramuscular, intravenous, subcutaneous. Current US regulatory status: approved.
Drug details — nalbuphine hydrochloride
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Patents
- 6
- Programs
- 8
- Data quality
- 0.84
Quick answer
nalbuphine hydrochloride (NALBUPHINE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta agonist. Route of administration: intramuscular, intravenous, subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
Opioid receptors; mu/kappa/delta agonist
Primary target: Opioid receptors; mu/kappa/delta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12274696
Methods of administering nalbuphine
granted -
US 10238646
Methods for treating pruritus
granted -
US 9624233
Compounds for treating pruritic conditions
granted -
US 8987289
Methods for treating pruritus
granted -
US 8940753
Methods for treating pruritis
granted -
US 6525062
Method of treating pain using nalbuphine and opioid antagonists
expired
Frequently asked questions
What is nalbuphine hydrochloride?
nalbuphine hydrochloride (NALBUPHINE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta agonist. Route of administration: intramuscular, intravenous, subcutaneous. Current US regulatory status: approved.
What is the brand name for nalbuphine hydrochloride?
NALBUPHINE HYDROCHLORIDE is a marketed brand name for nalbuphine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nalbuphine hydrochloride?
nalbuphine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.